Expanded Access Program for Treatment With Ecopipam for Tourette's Disorder
Clinical trial NCT07093541 · AVAILABLE
Trial details
- NCT number
- NCT07093541
- Sponsor
- Emalex Biosciences Inc.
- Status
- AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.